The consequences of alemtuzumab being restricted as a treatment for active MS should not be underestimated.
AHSCT vs. Alemtuzumab
AHSCT vs. Alemtuzumab
AHSCT vs. Alemtuzumab
The consequences of alemtuzumab being restricted as a treatment for active MS should not be underestimated.